Bicyclic heterocyclic derivatives having .alpha..sub.1 adrenergi

Details Bicyclic heterocyclic derivatives having .alpha..sub.1 adrenergi Bicyclic heterocyclic derivatives having .alpha..sub.1 adrenergi

1994-08-31

1997-02-25

Grumbling, Matthew V.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

546153, 546169, 546170, 546171, 546176, 546174, 546175, 546196, 546202, 546204, 5483044, 548491, 549 23, 549 49, 549362, 549398, 549401, 549403, 549405, 5142345, 5142322, 5142335, 514253, 514314, 514414, 514443, 514452, 514394, 514456, 514469, 540575, 544143, 544144, 544146, 544148, 544151, 544153, 544363, 544373, 544376, 544377, C07D24308, C07D41300, C07D21516, C07D23504, A61K 31395, A61K 3147, A61K 3138, A61K 31335

Patent

active

056058969

ABSTRACT:
This invention provides bicyclic heterocyclic derivatives and their pharmaceutically acceptable salts useful for the treatment of hypertension, urethral and lower urinary tract contractions, and other disorders. The compounds are also useful for binding .alpha..sub.1 -adrenergic and 5HT.sub.1A serotonergic receptors, in vitro or in vivo.

REFERENCES:
patent: 2921070 (1960-01-01), Da Re
patent: 3277094 (1966-10-01), Werner
patent: 3350411 (1967-10-01), Da Re
patent: 3810896 (1974-05-01), Witte et al.
patent: 4089969 (1978-05-01), Muchowski et al.
patent: 4495198 (1985-01-01), Wu
patent: 4539318 (1985-09-01), Baldwin et al.
patent: 4668804 (1987-05-01), Wu
patent: 4668805 (1987-05-01), Wu
patent: 4684651 (1987-08-01), Kikumoto et al.
patent: 4797498 (1989-01-01), Albrecht et al.
patent: 4940711 (1990-07-01), Nardi et al.
patent: 5091182 (1992-02-01), Ong et al.
patent: 5403847 (1995-04-01), Gluchowski
Testa et al. "Rec 15/2739 (SB 216469) a novel prostate selective .alpha..sub. -adrenoceptor antagonist", Pharmacology of Adrenoceptors, Jul. 21-23, 1994.
G. Sironi et al. "Rec 15/2739, a new .alpha..sub.1 -antagonist selective for the lower urinary tract: in vivo studies", Neurourology and Urodynamics 13(4), pp. 471-474, 1994,-(with poster presentation).
A. Leonardi, "Synthesis and pharmacological evaluation of new 4H-1-benzopyran derivates, uro-selective .alpha..sub.1 -adrenoceptor antagonists", XIIIth International Symposium on Medicinal Chem. -Paris-Sep. 19-23, 1994, p. 152-Abstract.
G. Motta et al, "Structural modification at the basic moiety of Rec 15/2739, a novel uro-selective .alpha..sub.1 -adrenoceptor antagonist", XIIIth International Symposium on Medicinal Chem.-Paris-Sep. 19-23, 1994, p. 153-Abstract.
R. Testa et al., "Rec 15/2739, a novel .alpha.-.sub.1 -antagonist selective for the lower urinary tract" 27.degree. Congresso Nazionale della Societ a Italiana di Farmacologia, Torino, 25-29 Sep. 1994,-Abstract.
Atassi et al., Eur. J. Med. Chem., 20:393-402 (1985).
Augstein et al., J. Med. Chem., 8:356-367 (1965).
Bagli, J. Med. Chem., 19:876-882 (1976).
Bonte et al., Eur. J. Med. Chem., 25:361-368 (1990).
Carroll et al., J. of Med. Chem., 19(9): 1111-1119 (1976).
Cunico et al., Org. Chem., 48:2780-2782 (1983).
Da Re, P. et al., Jahrg, 99:1962-1965, (1966).
Da Re, Ann. Chim., pp. 506-513 (1962).
Da Re et al., Eur. J. Med. Chem., 13;387-388 (1978).
Da Re, Il Farmaco-Ed. Sc., vol. XI:670-675 (1960).
Da Re et al., J. Med. Chem., 2(3): 263-269 (1960).
Engel et al., J. Med. Chem., 33:2976-2981 (1990).
Farina et al., Biochem. Pharm., 31:1887-1892 (1982).
Farina et al., Biochem. Pharm., 35:209-215 (1986).
Frishman et al., Cardiovascular Pharmacotherapy II, 72(2):427-440 (1988).
Garcia-Sainz et al., Biochemical and Biophysical Research Communications, 186(2):760-767 (1992).
Gartside et al., European Journal of Pharmacology, 191:391-400 (1990).
Grewal et al., J. Pharmac. Exp. Therap., 160(2):268-276 (1968).
Guarneri et al. Neurourol. Urodyn., 11:340-41 (1992).
Hamon et al., Annals New York Academy of Sciences, pp. 114-131 (1960).
Hartig et al., Drug Delivery Res., 26(3):215-224 (1992).
Laubie et al., Arzheim-Forsch, 19:1820-1826 (1969).
Leclerc et al., Arzheim-Forsch Drug. Res., 35:1357-1367 (1985).
Lyon, R. A. et al. J. Med. Chem., 29:630-634, (1986).
Martin, G. E. et al. J. Med. Chem., 32:1052-1056, (1989).
Mielke et al., Curr. Therap Res., 15(6):324-326 (1973).
Mull et al., J. Med. Chem., 8:332-338 (1965).
Overberger et al., J.A.C.S., 71:2661-2666 (1949).
Perez et al., Molecular Pharmacology, 40:876-883 (1991).
Ratouis et al., J. Med. Chem., 8:271-273 (1965).
Ratouis et al., J. Med. Chem., 8:104-107 (1965).
Romero et al., Annual Reports in Medical Chemistry, 27(3):21-30 (1992).
Saari et al., J. Med. Chem., 33:97-101 (1990).
Silvestrini et al., Arzheim-Forsch./Drug. Res., 32:668-673 (1982).
ten Hoeve, W. et al. J. Org. Chem., 58:5101-5105, (1993).
Traber et al., TIPS, 8:432-437 (1987).
Uneyama et al., Bull. Chem. Soc. Jpn., 58:2361-2365 (1985).
Valenti et al., Boll. Chim. Farm., 114:294-300 (1975).
Vizi et al., Medicinal Research Reviews, 6:431-449 (1986).
Wu et al., J. Med. Chem., 35:3519-3525 (1992).
Zifa et al., Pharmacological Reviews, 44(3): 401-458 (1992).
Drugs of the Future, 6:346-347 (1981).
Chemical Abstracts 55:5534a (1960).
Chemical Abstracts 59:2832b (1963).
Chemical Abstracts 63:11589h (1965).
Chemical Abstracts 66:37693s (1967).
Chemical Abstracts 66:85664e (1967).
Chemical Abstracts 67:64435m (1967).
Chemical Abstracts 74:22698p (1971).
Chemical Abstracts 76:14577z (1972).
Chemical Abstracts 78:584606 (1973).
Chemical Abstracts 98:107161d (1983).
Chemical Abstracts 83:131584c (1975).
Chemical Abstracts 84:59400u (1976).
Chemical Abstracts 100:103390q (1984).
Chemical Abstracts 104:109686v (1985).
Chemical Abstracts 104:19499g (1985).
Chemical Abstracts 105:78821z (1986).
Chemical Abstracts 107:236661v (1987).
Chemical Abstracts 108:15674v (1988).
Chemical Abstracts 108:37647r (1988).
Chemical Abstracts 108:150298r (1988).
Chemical Abstracts 109:128816g (1988).
Chemical Abstracts 110:135063h (1989).
Chemical Abstracts 111:153607p (1989).
Chemical Abstracts 112:216577x (1990).
Chemical Abstracts 113:109332n (1990).
Chemical Abstracts 116:262282c (1992).
Chemical Abstracts 59:10006g (1963).
Chemical Abstracts 81:20780e (1974).
Derwent Abstract, C93-164399 (1993).

Affiliated with

Also associated with

Rating

Bicyclic heterocyclic derivatives having .alpha..sub.1 adrenergi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic heterocyclic derivatives having .alpha..sub.1 adrenergi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic heterocyclic derivatives having .alpha..sub.1 adrenergi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1974097